FDA Approves Heart Lead

Medtronic has received FDA approval for its Attain StarFix OTW (over-the-wire) lead for the fixation of the heart during cardiac resynchronization therapy.

The device includes three soft, polyurethane lobes near the lead tip that enable stable placement in the target location when expanded. The lobes can be relaxed multiple times to reposition the lead as necessary. Once deployed, the electrode is securely fixed in place, reducing the potential for dislodgment, Medtronic said.

The product is expected to be available late this summer.